HHS Should Encourage Prospective Outcome Studies of Pharmacogenetic Drug Dosing, SACGHS Says
This article was originally published in The Pink Sheet Daily
Executive Summary
One example of the value of genotyping is Genentech's Herceptin, committee members agreed.